1. Absence of HTLV-1/2 infection and dermatological diseases in Manaus, State of Amazonas, Brazil
- Author
-
Leny Nascimento da Motta Passos, Paulo Roberto Lima Machado, Bruna Pedroso Tamegão-Lopes, José Alexandre Rodrigues de Lemos, Marcelo Távora Mira, Sinésio Talhari, and Márcia Poinho Encarnação de Moraes
- Subjects
Microbiology (medical) ,Adult ,Male ,medicine.medical_specialty ,lcsh:Arctic medicine. Tropical medicine ,lcsh:RC955-962 ,viruses ,Blotting, Western ,Blood Donors ,Enzyme-Linked Immunosorbent Assay ,Dermatology ,Association ,immune system diseases ,hemic and lymphatic diseases ,Prevalence ,Medicine ,Humans ,Human T-lymphotropic virus 1 ,Geographic area ,business.industry ,Dermatological diseases ,Human T-lymphotropic virus 2 ,virus diseases ,HTLV-I Infections ,HTLV-I Antibodies ,HTLV-II Antibodies ,Infectious Diseases ,Virus type ,HTLV-1/2 ,HTLV and skin diseases ,Dermatology clinic ,Immunology ,HTLV-II Infections ,Skin Diseases, Viral ,Parasitology ,Female ,business ,Brazil - Abstract
Introduction The prevalence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1/2) infection is heterogeneous across different populations. We tested the hypothesis that HTLV-1/2 infection occurs more often in dermatological patients. Methods A total of 1,091 patients from a tropical dermatology clinic were tested for HTLV-1/2. In parallel, 6865 first-time blood donors from the same geographic area were screened for HTLV-1/2; HTLV-1/2 positive blood donors underwent dermatological examinations. Results The prevalence of HTLV-1/2 in first-time blood donors was 0.14%. No co-occurrence of HTLV-1/2 infection and dermatological conditions was observed. Conclusions Our results challenge the hypothesis that HTLV-1/2 infection occurs more often in dermatological patients.
- Published
- 2014